Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Algita DX
- Development stage
- Phase 4
- Lead developer
- Labaid Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Algita DX is an oral dietary supplement and over-the-counter (OTC) formulation developed and manufactured by Labaid Pharmaceuticals. It is a combination product containing calcium carbonate derived from an algae source (equivalent to 500 mg of elemental calcium) and vitamin D3 (cholecalciferol, 200-400 IU). The use of algae-sourced calcium distinguishes it from traditional mineral-based calcium supplements. It is indicated for the treatment and prevention of conditions associated with calcium and vitamin D deficiency, including osteoporosis, rickets, osteomalacia, tetany, and hypoparathyroidism. It is also used to meet increased nutritional demands during pregnancy and lactation, or as supportive therapy for patients with kidney disease, pancreatitis, or those taking antiseizure medications.
- Brand names
- Algita DX
02
Targets
VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Algita DX.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Algita DX.